Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherArticle

Partial deletion of the nicotinic cholinergic receptor α4 and β2 subunit genes changes the acetylcholine sensitivity of receptor mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of α4 and β2 subunits

Cecilia Gotti, Milena Moretti, Natalie Meinerz, Franchesco Clementi, Annalisa Gaimarri, Allan C. Collins and Michael J. Marks
Molecular Pharmacology March 12, 2008, DOI: https://doi.org/10.1124/mol.108.045203
Cecilia Gotti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milena Moretti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Meinerz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Franchesco Clementi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annalisa Gaimarri
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan C. Collins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Marks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1124/mol.108.045203
PubMed 
18337473

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111

Article Versions

  • You are currently viewing an Earlier version of this article (March 12, 2008 - 10:55).
  • View the most recent version of this article

Author Information

Statistics from Altmetric.com

Article usage

Article usage: March 2008 to May 2022

AbstractFullPdf
Mar 200826066
Apr 200820038
May 200837764
Jun 2008381423
Jul 2008271213
Aug 2008231614
Sep 200819168
Oct 2008231115
Nov 20081775
Dec 200812310
Jan 200914127
Feb 200915107
Mar 200936105
Apr 20091473
May 2009365
Jun 20099139
Jul 200971510
Aug 20094127
Sep 200971910
Oct 2009467
Nov 2009521
Dec 2009820
Jan 20101964
Feb 20101249
Mar 2010685
Apr 20105108
May 2010795
Jun 20105107
Jul 2010812
Aug 20102975
Sep 20101665
Oct 201014812
Nov 201061211
Dec 2010654
Jan 2011364
Feb 2011825
Mar 2011986
Apr 2011957
May 2011428
Jun 2011648
Jul 20116108
Aug 201116119
Sep 2011171125
Oct 20111879
Nov 2011151112
Dec 201112911
Jan 201214310
Feb 2012943
Mar 20122286
Apr 20121569
May 20121188
Jun 2012723
Jul 20121847
Aug 201214128
Sep 20121335
Oct 2012847
Nov 20121666
Dec 2012676
Jan 20131868
Feb 201312107
Mar 20131067
Apr 201323157
May 20133056
Jun 2013463
Jul 2013801
Aug 2013645
Sep 20133144
Oct 20131034
Nov 2013542
Dec 2013437
Jan 20141222
Feb 2014555
Mar 2014956
Apr 2014742
May 20141388
Jun 20141053
Jul 20141211
Aug 2014268
Sep 2014696
Oct 20142854
Nov 20141776
Dec 20141762
Jan 20157312
Feb 20152166
Mar 20151865
Apr 20151110
May 201520810
Jun 20151193
Jul 2015745
Aug 201512105
Sep 20151934
Oct 2015425
Nov 2015231
Dec 2015623
Jan 20161185
Feb 201623113
Mar 2016141115
Apr 201620144
May 20161362
Jun 2016563
Jul 2016320
Aug 2016364
Sep 2016142
Oct 2016125
Nov 20162173
Dec 20162112
Jan 2017063
Feb 2017078
Mar 2017090
Apr 2017032
May 20170142
Jun 2017064
Jul 2017064
Aug 20171104
Sep 20170145
Oct 2017075
Nov 20170135
Dec 20173121
Jan 20183233
Feb 20180104
Mar 20181157
Apr 20180122
May 20181123
Jun 2018041
Jul 2018054
Aug 20180161
Sep 20180302
Oct 20180136
Nov 2018182
Dec 2018532
Jan 2019904
Feb 20191102
Mar 2019913
Apr 2019600
May 20191004
Jun 2019614
Jul 2019312
Aug 2019700
Sep 20191512
Oct 2019900
Nov 2019900
Dec 20191000
Jan 2020600
Feb 2020701
Mar 2020821
Apr 20201011
May 2020720
Jun 2020210
Jul 2020600
Aug 2020320
Sep 2020700
Oct 2020701
Nov 2020301
Dec 2020711
Jan 20211041
Feb 2021473
Mar 20211621
Apr 2021721
May 2021831
Jun 20212530
Jul 20211144
Aug 20211551
Sep 20211340
Oct 20211340
Nov 20211123
Dec 20211320
Jan 20221840
Feb 2022930
Mar 2022440
Apr 2022921
May 2022503

Next
Back to top

In this issue

Molecular Pharmacology: 101 (6)
Molecular Pharmacology
Vol. 101, Issue 6
1 Jun 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Partial deletion of the nicotinic cholinergic receptor α4 and β2 subunit genes changes the acetylcholine sensitivity of receptor mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of α4 and β2 subunits
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

Partial deletion of the nicotinic cholinergic receptor α4 and β2 subunit genes changes the acetylcholine sensitivity of receptor mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of α4 and β2 subunits

Cecilia Gotti, Milena Moretti, Natalie Meinerz, Franchesco Clementi, Annalisa Gaimarri, Allan C. Collins and Michael J. Marks
Molecular Pharmacology March 12, 2008, DOI: https://doi.org/10.1124/mol.108.045203

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherArticle

Partial deletion of the nicotinic cholinergic receptor α4 and β2 subunit genes changes the acetylcholine sensitivity of receptor mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of α4 and β2 subunits

Cecilia Gotti, Milena Moretti, Natalie Meinerz, Franchesco Clementi, Annalisa Gaimarri, Allan C. Collins and Michael J. Marks
Molecular Pharmacology March 12, 2008, DOI: https://doi.org/10.1124/mol.108.045203
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Polypharmacology of CBL0137 in the African Trypanosome
  • Peptide-mediated differential signaling at GPR83
  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics